HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Subramanian, S. Articles by Isaacson, K. Search for Related Content PubMed PubMed Citation Articles by Subramanian, S. Articles by Isaacson, K.

Outcome and Resource Use Associated With Myomectomy

From the Boston Scientific Corporation, Natick, Massachusetts; and Massachusetts General Hospital, Boston, Massachusetts.

Address reprint requests to: Mary Ann Clark, MHA, Boston Scientific Corporation, One Boston Scientific Place, Natick, MA 01760; E-mail: maryann.clark{at}bsci.com.

OBJECTIVE: To evaluate the outcomes and cost of myomectomy through retrospective claims data analysis.

METHODS: The study was performed using a retrospective database of private insurance claims from 1995 to 1997. Records were selected for analysis based on the presence of ICD-9-CM procedure and/or CPT-4 codes associated with myomectomy. In addition, diagnosis of uterine leiomyoma and related symptoms for these patients were confirmed through ICD-9-CM diagnosis codes. Inpatient, outpatient, and physician costs were estimated. All cost data were converted into 1997 dollars.

RESULTS: A total of 4394 women, between the ages of 14 and 70, were available for analysis. Of these, 3305 were classified by type of myomectomy procedure, and complete data were available on 820 at 1 year and 236 at 2 years. Abdominal myomectomies were the most common procedures, followed by hysteroscopic and laparoscopic myomectomies. Conversion to a more invasive procedure occurred in 5.4% of the patients. The rate of additional surgeries was 8.3% in 6 months, 10.6% in 1 year, and 16.5% in 2 years. Overall cost increased from an initial $6,737 per patient to $7,575 in 1 year and to $8,001 in 2 years.

CONCLUSION: The repeat procedures required after the initial myomectomy add significantly to total cost and highlight the importance of assessing post-procedure health care use. This comprehensive analysis facilitates the systematic evaluation of myomectomy with current and emerging alternative treatments for uterine leiomyomas.

This article has been cited by other articles:

				C. Recaldini, G. Carrafiello, D. Lagana, S. Cuffari, V. Bergamini, F. Ghezzi, and C. Fugazzola Percutaneous Sonographically Guided Radiofrequency Ablation of Medium-Sized Fibroids: Feasibility Study Am. J. Roentgenol., December 1, 2007; 189(6): 1303 - 1306. [Abstract] [Full Text] [PDF]

				M. K. Razavi, G. Hwang, A. Jahed, S. Modanloo, and B. Chen Abdominal Myomectomy Versus Uterine Fibroid Embolization in the Treatment of Symptomatic Uterine Leiomyomas Am. J. Roentgenol., June 1, 2003; 180(6): 1571 - 1575. [Abstract] [Full Text] [PDF]

				M. S. Broder, S. Goodwin, G. Chen, L. J. Tang, M. M. Costantino, M. H. Nguyen, T. N. Yegul, and H. Erberich Comparison of Long-Term Outcomes of Myomectomy and Uterine Artery Embolization Obstet. Gynecol., November 1, 2002; 100(5): 864 - 868. [Abstract] [Full Text] [PDF]